Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world
about
Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.Cost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model
P2860
Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cost-utility analysis of lopin ...... randomised trial to real world
@ast
Cost-utility analysis of lopin ...... randomised trial to real world
@en
Cost-utility analysis of lopin ...... randomised trial to real world
@nl
type
label
Cost-utility analysis of lopin ...... randomised trial to real world
@ast
Cost-utility analysis of lopin ...... randomised trial to real world
@en
Cost-utility analysis of lopin ...... randomised trial to real world
@nl
prefLabel
Cost-utility analysis of lopin ...... randomised trial to real world
@ast
Cost-utility analysis of lopin ...... randomised trial to real world
@en
Cost-utility analysis of lopin ...... randomised trial to real world
@nl
P2093
P2860
P50
P1433
P1476
Cost-utility analysis of lopin ...... randomised trial to real world
@en
P2093
Emanuela Foglia
Erminio Bonizzoni
Francesca Scolari
Giuliano Rizzardini
Umberto Restelli
P2860
P304
P356
10.1371/JOURNAL.PONE.0057777
P407
P577
2013-02-27T00:00:00Z